ArticlePregnancy hypertension2017
Labor therapeutics and BMI as risk factors for postpartum preeclampsia: A case-control study.
Article in Pregnancy hypertension, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta-analysis.BMC pregnancy and childbirth · 2024Pooled it
- Is postpartum preeclampsia a continuation of intrapartum preeclampsia? Maternal risk factors in intrapartum vs. postpartum preeclampsia: a retrospective cohort study.BMC pregnancy and childbirth · 2025Article
- Preeclampsia in Ghana: A study on the prevalence and risk factors of postpartum readmission in the Ashanti Region.Public health challenges · 2024Article
- Association between body mass index and chronic hypertension in patients with hypertension disorders of pregnancy one-year postpartum.Pregnancy hypertension · 2024Article
- Early Prediction of Hypertensive Diseases of Pregnancy by Using Combined Screening Methods in a Rural Population.Cureus · 2023Article
- A novel approach to joint prediction of preeclampsia and delivery timing using semicompeting risks.American journal of obstetrics and gynecology · 2023Article
- De Novo Postpartum Hypertension: Incidence and Risk Factors at a Safety-Net Hospital.Hypertension (Dallas, Tex. : 1979) · 2023Article
- Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy.American journal of obstetrics and gynecology · 2022Review
- Does body mass index impact assisted reproductive technology treatment outcomes in gestational carriers.Reproductive biology and endocrinology : RB&E · 2020Article
- Clinical Course, Associated Factors, and Blood Pressure Profile of Delayed-Onset Postpartum Preeclampsia.Obstetrics and gynecology · 2019Article
- Risk factors for the development of new-onset and persistent postpartum preeclampsia: A case-control study in Ghana.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
Abstract
objectivesThis study aims at identifying associations between therapeutics used during labor and the occurrence of postpartum preeclampsia (PPPE), a poorly understood entity. STUDY DESIGN AND
main outcome measuresThis is a case-control study of women who received an ICD-9 code for PPPE (cases) during the years 2009-2011, compared to women with a normotensive term pregnancy, delivery and postpartum period until discharge (controls), matched on age (±1year) and delivery date (±3months). Cases were defined as women having a normotensive term pregnancy, delivery and initial postpartum period (48h post-delivery) but developing hypertension between 48h and 6weeks postpartum. Single variable and multiple variable models were used to determine significant risk factors.
resultsForty-three women with PPPE were compared to 86 controls. Use of vasopressors and oxytocin did not differ between cases and controls, but rate of fluids administered during labor (OR=1.68 per 100cc/h; 95% CI: 1.09-2.59, p=0.02) and an elevated pre-pregnancy/first trimester BMI (OR=1.18 per kg/m
conclusionsWe identified two potentially modifiable risk factors for PPPE; further studies are needed to better define the role of these two variables in the development of PPPE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.